Drug Trial Radar · NCT06266767
Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia
Last checked: Nov 20, 2026Latest source record: Nov 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Feb 21, 2024
Primary completion
Oct 5, 2024
Study completion Oct 5, 2024
Sponsor
- Lead sponsor
- Hamad Medical CorporationIndustry
- Sponsor type
- Industry
- First posted
- Feb 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Health services research
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Epidural Analgesia remains the most effective form of pain relief in labour. After initiating epidural analgesia, there are many epidural drug regimens that can be employed to maintain analgesia for the duration of labour using an epidural catheter. Due to recent advances in medical technology, new epidural pumps, which allow both patient controlled epidural analgesia boluses (PCEA, a common standard of care in many hospitals) and programmed intermittent epidural boluses (PIEB, automatic boluses given in addition to the PCEA bolus), are now available. In this randomized double-blind trial, we aim to evaluate the effects of different combinations of PIEB (epidural bolus volume) and PIEB (bolus volume and time interval) on labour patient-controlled epidural analgesia (PCEA) usage. In theory, the more effective the PIEB combination (the ideal drug volume and ideal time interval), the less PCEA boluses (extra epidural drug) will be used as well as less clinician boluses and less lower limb weakness (motor block) as assessed by the Bromage Score.
Conditions
- Labor Pain
- Obstetric Pain
- Analgesia
Interventions
Levobupivacaine and FentanylDrug
Programmed Intermittent Epidural Bolus
Primary outcomes
What the sponsor says the trial is designed to measure.
- The volume of local anaesthetic mixture for breakthrough pain (PCEA + clinician bolus) + the Bromage ScoreTime frame: From the siting of the epidural block to the delivery of the fetus (maximum 24 hrs)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hamad Medical Corporation (HMC)
Doha, Baladiyat ad Dawhah, Qatar
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.